FDA Adverse Event Injury Summary report: N

PROSTAR XL SUTURE-MEDIATED CLOSURE

MDR report key: 2840645 · Received November 20, 2012

Report

Report Number
2024168-2012-07328
Event Type
Injury
Date Received
November 20, 2012
Date of Event
October 29, 2012
Report Date
October 30, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
MGB
PMA / PMN Number
P960043
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE DEVICE WAS RECEIVED. THE INVESTIGATION IS NOT YET COMPLETE. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION. THE RIGHT COMMON FEMORAL ARTERY WAS REPORTEDLY HEAVILY CALCIFIED. THE PROSTAR XL INSTRUCTIONS FOR USE STATE UNDER SPECIAL PATIENT POPULATIONS THAT THE SAFETY AND EFFECTIVENESS HAVE NOT BEEN ESTABLISHED, IN PATIENTS WITH COMMON FEMORAL ARTERY CALCIUM, WHICH IS FLUOROSCOPICALLY VISIBLE.

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR EVALUATION. THE REPORTED FAILURE OF THE NEEDLES TO DEPLOY WAS NOT CONFIRMED AS ANALYSIS OF THE DEVICE DID NOT DETECT ANY DAMAGE OR ANOMALY OF THE DEVICE THAT MAY HAVE CONTRIBUTED TO THE REPORTED EXPERIENCE. BASED ON VISUAL INSPECTION AND FUNCTIONAL TESTING THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT PRIOR TO AN ENDOVASCULAR ANEURYSM REPAIR (EVAR) PROCEDURE, PRE-CLOSE PLACEMENT OF THE SUTURES WAS ATTEMPTED IN A 10-FRENCH SIZED HEAVILY CALCIFIED RIGHT COMMON FEMORAL ARTERY USING A PROSTAR XL DEVICE. REPORTEDLY, HOLDING THE DEVICE HELD AT AN ANGLE OF 45 DEGREES TO THE LONGITUDINAL PLANE OF THE ARTERY, THE HANDLE OF THE DEVICE WAS PULLED TO DEPLOY THE NEEDLES, BUT ONLY THREE OF THE FOUR NEEDLES PRESENTED AT THE HUB OF THE DEVICE. TENSION WAS APPLIED TO THE SUTURES TO GET THEM BACK INTO THE DEVICE. ALTHOUGH DIFFICULTY WAS ENCOUNTERED DURING BACKDOWN OF THE NEEDLES BACK INTO THE PROSTAR SHEATH, THE NEEDLES WERE SUCCESSFULLY BACKEDDOWN. IT WAS NOT POSSIBLE TO GET THE SUTURES ALL THE WAY BACK IN THE SYSTEM. THE PROSTAR XL DEVICE WAS REMOVED, BUT BECAUSE A LARGE AMOUNT OF BLOOD LEAKED FROM THE ACCESS SITE, IT WAS NOT POSSIBLE TO USE ANOTHER PROSTAR XL DEVICE. THE BLOOD LEAK WAS MANAGED AND AFTER SUCCESSFUL EVAR PROCEDURE, A SURGICAL CUT DOWN WAS PERFORMED AND THE VESSEL WAS SURGICALLY SUTURED TO ACHIEVE HEMOSTASIS. THE EVAR PROCEDURE WAS PERFORMED UNDER LOCAL ANESTHESIA. THERE WERE NO REPORTED ADVERSE PATIENT SEQUELAE AND NO REPORTED SIGNIFICANT CLINICAL DELAY IN THE PROCEDURE. THE PHYSICIAN WAS REPORTED TO BE TRAINED IN THE USE OF THE PROSTAR XL DEVICE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROSTAR XL SUTURE-MEDIATED CLOSURE SUTURE MEDIATED CLOSURE MGB AV-TEMECULA-CT 20710K1

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention SHEATH: 10-FRENCH. HEPARIN